Clinical trials
Phase 2/3 Pulmonary Disease, Chronic Obstructive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 4 |
| 2006 | 2 |
| 2007 | 2 |
| 2009 | 6 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Unknown status | 4 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aeris Therapeutics | 2 |
| Novartis | 2 |
| Patrick Murphy | 2 |
| AstraZeneca | 1 |
| Barts & The London NHS Trust | 1 |
| Bastiaan Driehuys | 1 |
| BeerYaakov Mental Health Center | 1 |
| Beni-Suef University | 1 |
| Broncus Technologies | 1 |
| C. T. Lamont Primary Care Research Centre | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Disease, Chronic Obstructive | 38 |
| Emphysema | 4 |
| Heart Failure | 3 |
| Lung Diseases | 3 |
| Lung Diseases, Obstructive | 3 |
| Pulmonary Emphysema | 3 |
| Respiratory Aspiration | 3 |
| Asthma | 2 |
| Hypertension | 2 |
| Pathologic Processes | 2 |
Trials
Showing 76 to 38 of 38. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.